Form D · Biotechnology
ACHIEVE LIFE SCIENCES, INC.
Vancouver, B.C., A1 · CIK 0000949858
Offering snapshot reported Dec 8, 2022 · SEC filing
- Reported sold
- $18.9M Offering amount: $25M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 18, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2022 | Amendment | $18,900,000 | $0vs Nov 29, 2022 | 16 | SEC filing |
| Nov 29, 2022 | Initial | $18,900,000 | No comparison | 16 | SEC filing |
| Jan 4, 2010 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Nov 2, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 31, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $756K
- Form D file number
- 021-465960
Units consisting of two shares of common stock and one common stock warrant.
Source: Form D, filed Dec 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Anderson | Executive |
| John Bencich | Director, Executive |
| Michelle Burris | Director |
| Anthony Clarke | Executive |
| Neil James Clendeninn | Director |
| Scott Cormack | Director, Executive |
| Vaughn Himes | Director |
| Cindy Jacobs | Director, Executive |
| Donald Joseph | Director |
| Bridget Martell | Director |
| Michael A. Martino | Director |
| Martin Mattingly | Director |
| Jay Moyes | Director |
| Richard Stewart | Director |
| Dwight Winstead | Director |
| Jaime Xinos | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Vancouver, B.C., A1, V6E 4H1